Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Medtronic
Moodys
Covington
Baxter
Boehringer Ingelheim
Queensland Health
QuintilesIMS
Harvard Business School

Generated: December 12, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR CORTISONE ACETATE

« Back to Dashboard

Clinical Trials for Cortisone Acetate

Trial ID Title Status Sponsor Phase Summary
NCT00489840 Treatment of Chronic Central Serous Chorioretinopathy With Open-Label Anecortave Acetate Completed Alcon Research Phase 1/Phase 2 Investigation to evaluate Anecortave Acetate in the treatment of chronic central serous chorioretinopathy
NCT00489840 Treatment of Chronic Central Serous Chorioretinopathy With Open-Label Anecortave Acetate Completed LuEsther T. Mertz Retinal Research Center Phase 1/Phase 2 Investigation to evaluate Anecortave Acetate in the treatment of chronic central serous chorioretinopathy
NCT00489840 Treatment of Chronic Central Serous Chorioretinopathy With Open-Label Anecortave Acetate Completed Manhattan Eye, Ear & Throat Hospital Phase 1/Phase 2 Investigation to evaluate Anecortave Acetate in the treatment of chronic central serous chorioretinopathy
NCT00915343 Once-daily Oral Modified Release Hydrocortisone in Patients With Adrenal Insufficiency Completed Shire Phase 2/Phase 3 This is a randomised, controlled, open, two-armed, two-period cross-over, multi-centre phase II/III study to assess the safety, tolerability and pharmacokinetics of once-daily oral modified-release hydrocortisone in comparison to conventional thrice-daily oral hydrocortisone tablets in patients with adrenal insufficiency
NCT01771328 Continuous Subcutaneous Hydrocortisone Infusion in Congenital Adrenal Hyperplasia Recruiting Haukeland University Hospital Phase 2 The conventional glucocorticoid replacement therapy in congenital adrenal hyperplasia (CAH) renders the cortisol levels unphysiological, which may cause symptoms and long-term complications. Glucocorticoid replacement is technically feasible by continuous subcutaneous hydrocortisone infusion (CSHI), and can mimic the normal diurnal cortisol rhythm. This method was recently applied to treat a patient through a critical phase of puberty. This is a clinical trial aiming to evaluate CSHI treatment in patients with CAH. The main objective is to determine the effects of CSHI on metabolic parameters (androstenedione and 17-hydroxyprogesterone profiles, and testosterone,adrenocorticotropic hormone(ACTH), cortisol, and bone markers), and to determine the required glucocorticoid doses. Secondary objectives are to determine effects on clinical status, body weight, blood pressure and other metabolic parameters, as well as on subjective health status (AddiQoL, SF36).
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Cortisone Acetate

Condition Name

Condition Name for Cortisone Acetate
Intervention Trials
Flail Chest 1
Degeneration of Lumbar or Lumbosacral Intervertebral Disc 1
Chronic Central Serous Chorioretinopathy 1
Atrial Fibrillation 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Cortisone Acetate
Intervention Trials
Hyperplasia 1
Flail Chest 1
Adrenogenital Syndrome 1
Atrial Fibrillation 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Cortisone Acetate

Trials by Country

Trials by Country for Cortisone Acetate
Location Trials
Norway 2
Israel 1
United States 1
Brazil 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Cortisone Acetate
Location Trials
New York 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Cortisone Acetate

Clinical Trial Phase

Clinical Trial Phase for Cortisone Acetate
Clinical Trial Phase Trials
Phase 4 1
Phase 2/Phase 3 2
Phase 2 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Cortisone Acetate
Clinical Trial Phase Trials
Completed 3
Recruiting 2
Not yet recruiting 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Cortisone Acetate

Sponsor Name

Sponsor Name for Cortisone Acetate
Sponsor Trials
Haukeland University Hospital 2
Hadassah Medical Organization 1
Shire 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Cortisone Acetate
Sponsor Trials
Other 8
Industry 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Julphar
Baxter
McKinsey
Queensland Health
Merck
Farmers Insurance
Citi
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.